Business · 26/09/2006Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for KETEK Patent Extension
Summary
The Food and Drug Administration (FDA) has officially confirmed the review period for KETEK's patent extension application, which seeks to prolong the patent protection for a human drug product, as mandated by law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →